Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer
Author(s) -
Rachel Evans,
Fabián Flores-Borja,
Sissiri,
Elena Miranda,
Katherine Lawler,
Anita Grigoriadis,
James Monypenny,
Cheryl Gillet,
Julie Owen,
Peter M. Gordon,
Victoria Male,
Anthony Cheung,
Farzaoor,
Paul R. Barber,
Rebecca Marlow,
Erika Francesch-Domenech,
Gilbert O. Fruhwirth,
Mario Leonardo Squadrito,
Borivoj Vojnovic,
Andrew Tutt,
Frederic Festy,
Michele De Palma,
Tony Ng
Publication year - 2019
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2019.04.076
Subject(s) - cancer research , integrin , metastasis , rhoa , microbiology and biotechnology , cell adhesion , macrophage , biology , signal transduction , chemistry , medicine , cancer , cell , biochemistry , genetics , in vitro
Lymphatic vasculature is crucial for metastasis in triple-negative breast cancer (TNBC); however, cellular and molecular drivers controlling lymphovascular metastasis are poorly understood. We define a macrophage-dependent signaling cascade that facilitates metastasis through lymphovascular remodeling. TNBC cells instigate mRNA changes in macrophages, resulting in β4 integrin-dependent adhesion to the lymphovasculature. β4 integrin retains macrophages proximal to lymphatic endothelial cells (LECs), where release of TGF-β1 drives LEC contraction via RhoA activation. Macrophages promote gross architectural changes to lymphovasculature by increasing dilation, hyperpermeability, and disorganization. TGF-β1 drives β4 integrin clustering at the macrophage plasma membrane, further promoting macrophage adhesion and demonstrating the dual functionality of TGF-β1 signaling in this context. β4 integrin-expressing macrophages were identified in human breast tumors, and a combination of vascular-remodeling macrophage gene signature and TGF-β signaling scores correlates with metastasis. We postulate that future clinical strategies for patients with TNBC should target crosstalk between β4 integrin and TGF-β1.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom